Colorectal cancer, also known as colon cancer or rectal cancer, is a malignant tumor that forms in the colon (large intestine) or rectum (final part of the digestive tract before the anus). It originates from the inner lining of these gastrointestinal segments. Colorectal cancer molecular diagnostics involve advanced techniques to identify specific genetic mutations, alterations, and biomarkers crucial for understanding the development, progression, and treatment response of colorectal cancer.
The primary components of colorectal cancer molecular diagnostics include instruments, reagents, kits, and services. Instruments are specialized tools or devices designed for analyzing and detecting molecular changes, such as genetic mutations, variations in gene expression, or specific biomolecules, within biological samples from patients with colorectal cancer. Molecular diagnostic solutions employ technologies such as polymerase chain reaction (PCR), sequencing, mass spectrometry, transcription-mediated amplification, chips and microarrays, and isothermal nucleic acid amplification technology (INAAT). These diagnostics are utilized by various end-users, including hospitals, ambulatory surgical centers, diagnostic laboratories, and homecare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The colorectal cancer molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer molecular diagnostics market statistics, including colorectal cancer molecular diagnostics industry global market size, regional shares, competitors with a colorectal cancer molecular diagnostics market share, detailed colorectal cancer molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer molecular diagnostics industry. This colorectal cancer molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The colorectal cancer molecular diagnostics market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing incidence of colorectal cancer, growing awareness, and screening initiatives, rising emphasis on personalized medicine, government initiatives for cancer control.
The colorectal cancer molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to aging population and increased risk factors, integration of genomic data into clinical practice, rise in precision medicine approaches, global efforts in cancer research and collaboration. Major trends in the forecast period include increasing emphasis on early detection biomarkers, integration of artificial intelligence (AI) in data analysis, rise of circulating tumor DNA (CTDNA) analysis, expansion of companion diagnostics for targeted therapies, focus on immunotherapy biomarkers.
The forecast of 8.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of (Microsatellite Instability)MSI testing kits and RAS mutation panels sourced from Germany and South Korea, thereby delaying precision oncology decisions and elevating molecular pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of inflammatory bowel diseases (IBD) is projected to drive the growth of the colorectal cancer molecular diagnostic market in the future. Inflammatory bowel diseases (IBD) are chronic gastrointestinal disorders marked by inflammation of the digestive tract, primarily affecting the colon and rectum, and are associated with symptoms such as abdominal pain, diarrhea, and weight loss. These conditions are typically managed through medications, lifestyle modifications, and sometimes surgery. The growing incidence of IBD is increasing the demand for accurate, efficient, and advanced diagnostic solutions, which are crucial since determining systemic therapy for colorectal cancer (CRC) largely depends on the results obtained from molecular assessments of the tumor. For instance, in April 2024, research conducted by Crohn's & Colitis UK revealed that approximately 500,000 people in the UK are living with inflammatory bowel disease (IBD), nearly double previous estimates. Therefore, the rising incidences of inflammatory bowel diseases (IBD) will propel the growth of the colorectal cancer molecular diagnostic market.
The escalating prevalence of colorectal cancer is forecasted to drive the growth of the colorectal cancer molecular diagnostics market. Colorectal cancer affects the colon or rectum, resulting from the uncontrolled growth of cells in these digestive system areas, leading to tumor formation. The upsurge in colorectal cancer cases intensifies the demand for molecular diagnostic tools crucial in cancer detection and treatment. As highlighted by the American Cancer Society in March 2023, an estimated 153,020 individuals are anticipated to receive a colorectal cancer diagnosis, with around 52,550 projected deaths. This forecast includes 19,550 cases and 3,750 deaths among individuals under 50 years old. Thus, the rising prevalence of colorectal cancer is a key driver fueling growth within the colorectal cancer molecular diagnostics market.
Major companies are dedicated to pioneering innovative solutions in molecular diagnostics and personalized medicine, exemplified by the introduction of the Shield Blood Test approach for early-stage colorectal cancer detection. Guardant Health, a prominent US-based biotechnology company specializing in oncology molecular diagnostic products, launched the Shield Blood Test in May 2022. This groundbreaking blood test offers a convenient screening method involving a simple blood draw, addressing challenges associated with patient reluctance to undergo screening. The test demonstrated a sensitivity of 91% for detecting colorectal cancer and 20% for identifying advanced adenomas, with a specificity of 92%. Leveraging data from diverse cohorts comprising over 2,000 individuals with colorectal cancer, 357 with advanced adenoma, and 3,757 healthy subjects, the Shield test identifies early signals of colorectal cancer in the blood.
In July 2023, New Day Diagnostics LLC, a reputable US-based medical equipment manufacturing company, completed the acquisition of Epigenomics AG assets for an undisclosed sum. This strategic acquisition broadens New Day Diagnostics' portfolio in the realm of cancer diagnostics by acquiring intellectual property from Epigenomics AG. Notably, the acquisition includes Epi ProColon, an innovative screening technology specifically designed for the non-invasive detection of colorectal cancer. Epigenomics AG, headquartered in Germany, is a recognized player in the field of colorectal cancer molecular diagnostics, emphasizing the development of cutting-edge technologies for cancer detection.
Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.
North America was the largest region in the colorectal cancer molecular diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the colorectal cancer molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The colorectal cancer molecular diagnostics market consists of revenues earned by entities by providing diagnostic genetic mutation analysis, biomarker profiling, and epigenetic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal cancer molecular diagnostics market consists of sales of molecular diagnostic biochips, liquid biopsy kits, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Colorectal Cancer Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on colorectal cancer molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for colorectal cancer molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The colorectal cancer molecular diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Instruments; Reagents And Kits; Services
- 2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
- 3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
- Subsegments:
- 1) By Instruments: PCR Machines; Sequencers; Microarrays
- 2) By Reagents And Kits: DNA Or RNA Extraction Kits; Assay Kits; Reagent Packs
- 3) By Services: Diagnostic Testing Services; Genetic Testing Services; Consultation Services
- Companies Mentioned: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; Biocartis Group NV; Agilent Technologies Inc.; Grifols S.A; Hologic Inc.; Biomerieux SA; Quidel Corporation; Bio-Rad Laboratories Inc.; Qiagen N.V.; Exact Sciences Corporation; Illumina Inc.; Cepheid; Myriad Genetics Inc.; Guardant Health; Luminex Corporation; GenMark Diagnostics; Amoy Diagnostics Co. Ltd.; MDxHealth Inc.; HTG Molecular Diagnostics Inc.; GenPath Diagnostics; geneOmbio Technologies Pvt.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Colorectal Cancer Molecular Diagnostics Market Characteristics
3. Colorectal Cancer Molecular Diagnostics Market Trends And Strategies
4. Colorectal Cancer Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Colorectal Cancer Molecular Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Colorectal Cancer Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Colorectal Cancer Molecular Diagnostics Market Growth Rate Analysis
- 5.4. Global Colorectal Cancer Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Colorectal Cancer Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Colorectal Cancer Molecular Diagnostics Total Addressable Market (TAM)
6. Colorectal Cancer Molecular Diagnostics Market Segmentation
- 6.1. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Instruments
- Reagents And Kits
- Services
- 6.2. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymerase Chain Reaction (PCR)
- Sequencing
- Mass Spectrometry
- Transcription Mediated Amplification
- Chips And Microarrays
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- 6.3. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Homecare Settings
- 6.4. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- PCR Machines
- Sequencers
- Microarrays
- 6.5. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Or RNA Extraction Kits
- Assay Kits
- Reagent Packs
- 6.6. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Testing Services
- Genetic Testing Services
- Consultation Services
7. Colorectal Cancer Molecular Diagnostics Market Regional And Country Analysis
- 7.1. Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market
- 8.1. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Colorectal Cancer Molecular Diagnostics Market
- 9.1. China Colorectal Cancer Molecular Diagnostics Market Overview
- 9.2. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Colorectal Cancer Molecular Diagnostics Market
- 10.1. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Colorectal Cancer Molecular Diagnostics Market
- 11.1. Japan Colorectal Cancer Molecular Diagnostics Market Overview
- 11.2. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Colorectal Cancer Molecular Diagnostics Market
- 12.1. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Colorectal Cancer Molecular Diagnostics Market
- 13.1. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Colorectal Cancer Molecular Diagnostics Market
- 14.1. South Korea Colorectal Cancer Molecular Diagnostics Market Overview
- 14.2. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Colorectal Cancer Molecular Diagnostics Market
- 15.1. Western Europe Colorectal Cancer Molecular Diagnostics Market Overview
- 15.2. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Colorectal Cancer Molecular Diagnostics Market
- 16.1. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Colorectal Cancer Molecular Diagnostics Market
- 17.1. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Colorectal Cancer Molecular Diagnostics Market
- 18.1. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Colorectal Cancer Molecular Diagnostics Market
- 19.1. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Colorectal Cancer Molecular Diagnostics Market
- 20.1. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Colorectal Cancer Molecular Diagnostics Market
- 21.1. Eastern Europe Colorectal Cancer Molecular Diagnostics Market Overview
- 21.2. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Colorectal Cancer Molecular Diagnostics Market
- 22.1. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Colorectal Cancer Molecular Diagnostics Market
- 23.1. North America Colorectal Cancer Molecular Diagnostics Market Overview
- 23.2. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Colorectal Cancer Molecular Diagnostics Market
- 24.1. USA Colorectal Cancer Molecular Diagnostics Market Overview
- 24.2. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Colorectal Cancer Molecular Diagnostics Market
- 25.1. Canada Colorectal Cancer Molecular Diagnostics Market Overview
- 25.2. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Colorectal Cancer Molecular Diagnostics Market
- 26.1. South America Colorectal Cancer Molecular Diagnostics Market Overview
- 26.2. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Colorectal Cancer Molecular Diagnostics Market
- 27.1. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Colorectal Cancer Molecular Diagnostics Market
- 28.1. Middle East Colorectal Cancer Molecular Diagnostics Market Overview
- 28.2. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Colorectal Cancer Molecular Diagnostics Market
- 29.1. Africa Colorectal Cancer Molecular Diagnostics Market Overview
- 29.2. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape
- 30.2. Colorectal Cancer Molecular Diagnostics Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
31. Colorectal Cancer Molecular Diagnostics Market Other Major And Innovative Companies
- 31.1. Biocartis Group NV
- 31.2. Agilent Technologies Inc.
- 31.3. Grifols S.A
- 31.4. Hologic Inc.
- 31.5. Biomerieux SA
- 31.6. Quidel Corporation
- 31.7. Bio-Rad Laboratories Inc.
- 31.8. Qiagen N.V.
- 31.9. Exact Sciences Corporation
- 31.10. Illumina Inc.
- 31.11. Cepheid
- 31.12. Myriad Genetics Inc.
- 31.13. Guardant Health
- 31.14. Luminex Corporation
- 31.15. GenMark Diagnostics
32. Global Colorectal Cancer Molecular Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market
34. Recent Developments In The Colorectal Cancer Molecular Diagnostics Market
35. Colorectal Cancer Molecular Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Colorectal Cancer Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Colorectal Cancer Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Colorectal Cancer Molecular Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
